Crossmark

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand

Crossref DOI link: https://doi.org/10.1186/1472-6963-14-170

Published Online: 2014-04-14

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tantai, Narisa

Chaikledkaew, Usa

Tanwandee, Tawesak

Werayingyong, Pitsaphun

Teerawattananon, Yot
License Information

License valid from 2014-04-14
More Information

Article History

Received: 21 September 2013

Accepted: 9 April 2014

First Online: 14 April 2014